MedPath

EFFECT OF VISCERAL MANIPULATION ON VARIATION IN ALANINE TRANSAMINASE LEVELS AND LIVER MOBILITY USING ULTRASONOGRAPY IN INDIVIDUALS WITH FATTY LIVER: AN EXPERIMENTAL STUDY

Phase 1
Completed
Conditions
Health Condition 1: K70-K77- Diseases of liver
Registration Number
CTRI/2023/10/059093
Lead Sponsor
EHA KOPPER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
18
Inclusion Criteria

1-Alanine transaminase levels more than 35 -79 U/L for men and 31-55 U/L for women.

2-The controlled Attenuation parameter (CAP) score more than 238dB/m on ultrasonograpy

3-Stage 1 and 2 of fatty liver

Exclusion Criteria

1-Liver cirrhosis

2-Jaundice

3-Rib fracture

4-COPD

5-Hepatitis A,B,C

6-Amyloidosis

7-Hepatomegaly

8-Subject on any medication like antibiotics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Ultrasonograpy of liver <br/ ><br>Timepoint: Baseline and at 2 weeks
Secondary Outcome Measures
NameTimeMethod
Alanine transaminase testTimepoint: Baseline & at 2 weeks
© Copyright 2025. All Rights Reserved by MedPath